US Tech 100

19,804.00

0.64%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

OPGN

OpGen (OPGN)

OpGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OPGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
05/04/2023	4:30PM	GlobeNewswire Inc.	OpGen Announces Closing of $3.5 Million Public Offering	NASDAQ:OPGN	OpGen Inc
05/03/2023	4:44PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OPGN	OpGen Inc
05/03/2023	4:42PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:OPGN	OpGen Inc
05/03/2023	4:41PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:OPGN	OpGen Inc
05/03/2023	4:38PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:OPGN	OpGen Inc
05/01/2023	9:00PM	GlobeNewswire Inc.	OpGen Announces Pricing of $3.5 Million Public Offering	NASDAQ:OPGN	OpGen Inc
04/27/2023	4:36PM	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OPGN	OpGen Inc
04/26/2023	4:35PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:OPGN	OpGen Inc
04/26/2023	4:30PM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND	NASDAQ:OPGN	OpGen Inc
04/26/2023	4:18PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OPGN	OpGen Inc
04/19/2023	8:08AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
04/18/2023	4:30PM	GlobeNewswire Inc.	OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare	NASDAQ:OPGN	OpGen Inc
04/18/2023	7:30AM	GlobeNewswire Inc.	OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel	NASDAQ:OPGN	OpGen Inc
04/07/2023	4:47PM	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:OPGN	OpGen Inc
04/05/2023	7:30AM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FIND	NASDAQ:OPGN	OpGen Inc
04/03/2023	7:30AM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics	NASDAQ:OPGN	OpGen Inc
03/31/2023	4:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/31/2023	4:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/30/2023	2:25PM	GlobeNewswire Inc.	CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
03/29/2023	4:15PM	GlobeNewswire Inc.	OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
03/22/2023	7:30AM	GlobeNewswire Inc.	OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time	NASDAQ:OPGN	OpGen Inc
03/14/2023	12:49PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
03/06/2023	5:17PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/06/2023	5:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/06/2023	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
03/01/2023	7:30AM	GlobeNewswire Inc.	OpGen Subsidiary Ares Genetics Announces its Move to New Vienna Location and Provides Update on Business Growth	NASDAQ:OPGN	OpGen Inc
02/17/2023	8:56AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
02/17/2023	7:30AM	GlobeNewswire Inc.	OpGen Announces Exercise of All Prefunded Warrants	NASDAQ:OPGN	OpGen Inc
01/26/2023	7:30AM	GlobeNewswire Inc.	OpGen subsidiary Ares Genetics announces granting of key patent in China	NASDAQ:OPGN	OpGen Inc
01/23/2023	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc